A novel <i>SLC1A1‐RIC1</i> fusion sensitive to asparaginase‐based therapy in natural killer/T‐cell lymphoma-Reference-Cited by-同舟云学术

A novel SLC1A1‐RIC1 fusion sensitive to asparaginase‐based therapy in natural killer/T‐cell lymphoma

Published:2023-09 Issue:3 Volume:203 Page:485-489
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Xiong Jie¹^ORCID,Zhao Wei‐Li¹²^ORCID

Affiliation:

1. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

2. Laboratory of Molecular Pathology Pôle de Recherches Sino‐Français en Science du Vivant et Génomique Shanghai China

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Samuel Waxman Cancer Research Foundation

Shanghai Jiao Tong University

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19066

Reference12 articles.

1. NK-/T-cell lymphomas

2. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma

3. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia

4. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

5. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Amino Acid Transporter SLC1 Family as Tumor Therapeutic Targets;Hans Journal of Biomedicine;2024